Issue Date: November 2, 2015
Big Pharma On Repeat
One notices from the juicy Aug. 3 issue of C&EN that the big pharma broken record is still spinning mightily. Specifically, it appears that big pharma is, as usual, in Brownian motion mode. For example, A acquires B,C outsources its R&D, D and E contract with China or India to produce “stuff,” F slashes its chemistry staff, while the overpaid chief executive officer serves as the company mouthpiece, blah, blah, blah.
And to add insult to injury, A through F and myriad others are moving to Boston (page 13)! So, where, in the midst of all this churning, is a product such as a cure for cancer or a cure for diabetes or cystic fibrosis? Maybe the black hole for talent and money that is evolving in Massachusetts can cough up some results, maybe sometime?
Palm Desert, Calif.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society